価格表

在庫・価格 : 2024年05月03日 12時39分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
α1-Acid Glycoprotein, Human, ELISA Kit, AssayMax (96well)
EG5001-1 ANGアッセイプロ
AssayPro
1 kit ¥70,000
(未発注)
追加

在庫・価格 : 2024年05月03日 12時39分 現在

α1-Acid Glycoprotein, Human, ELISA Kit, AssayMax (96well)

  • 商品コード:EG5001-1
  • メーカー:ANG
  • 包装:1kit
  • 価格: ¥70,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Chance M et al. (2011) PROTEIN BIOMARKERS AND THERAPEUTIC TARGETS FOR RENAL DISORDERS. United States Patent Application 20120329071

PubMed
2 Ofotokun I et al. (2011) Immune activation mediated change in alpha-1-Acid glycoprotein: impact on total and free lopinavir plasma exposure. J Clin Pharmacol. 51(11):1539-48

PubMed
3 Alfadda AA et al. (2012) Orosomucoid serum concentrations and fat depot-specific mRNA and protein expression in humans. Mol Cells. 33(1):35-41

PubMed
4 Schlatzer D et al. (2012) Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes. Diabetes Care. 35(3):549-55. Epub 2012 Jan 11

PubMed
5 Lv M et al. (2013) Ceruloplasmin Is a Potential Biomarker for aGvHD following Allogeneic Hematopoietic Stem Cell Transplantation. PLoS One 8(3):e58735

PubMed
6 Alfadda AA (2014) Circulating Adipokines in Healthy versus Unhealthy Overweight and Obese Subjects. Int J Endocrinol. 2014:170434. doi: 10.1155/2014/170434. Epub 2014 Jan 16

PubMed
7 Martos-Moreno GA et al. (2014) Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children. Int J Pediatr Endocrinol. 2014(1):9. doi: 10.1186

PubMed
  • No.: 1
  • 文献情報:
    Chance M et al. (2011) PROTEIN BIOMARKERS AND THERAPEUTIC TARGETS FOR RENAL DISORDERS. United States Patent Application 20120329071

  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Ofotokun I et al. (2011) Immune activation mediated change in alpha-1-Acid glycoprotein: impact on total and free lopinavir plasma exposure. J Clin Pharmacol. 51(11):1539-48

  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Alfadda AA et al. (2012) Orosomucoid serum concentrations and fat depot-specific mRNA and protein expression in humans. Mol Cells. 33(1):35-41

  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Schlatzer D et al. (2012) Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes. Diabetes Care. 35(3):549-55. Epub 2012 Jan 11

  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Lv M et al. (2013) Ceruloplasmin Is a Potential Biomarker for aGvHD following Allogeneic Hematopoietic Stem Cell Transplantation. PLoS One 8(3):e58735

  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Alfadda AA (2014) Circulating Adipokines in Healthy versus Unhealthy Overweight and Obese Subjects. Int J Endocrinol. 2014:170434. doi: 10.1155/2014/170434. Epub 2014 Jan 16

  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Martos-Moreno GA et al. (2014) Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children. Int J Pediatr Endocrinol. 2014(1):9. doi: 10.1186

  • 備考:
  • 参照:
    PubMed